Events

Webinar: “Response to the COVID-19 Pandemic: Lessons from Japan and Abroad”

Webinar: “Response to the COVID-19 Pandemic: Lessons from Japan and Abroad”

+ Thank you to those who took part in the webinar!
Have a look at our article to find out what was discussed!

Join us for a webinar with renowned vaccination expert Prof. Dr. Kenji Shibuya, Director of the University Institute for Population Health at King’s College London!

With millions of vaccines doses being distributed in most economically developed nations, the end of the COVID-19 pandemic finally appears to be in sight. The pace and scale of this crisis, however, has dramatically challenged the ability of health agencies and regulatory bodies around the world, including Japan.
In this webinar for the SCCIJ, Prof. Shibuya will present the global state of the pandemic, the expected roll-out of the COVID-19 vaccine in Japan, and the implications of the pandemic for the country. A Q&A session will follow.

Date:

Tuesday, April 6, 2021

Time:

19:00-20:00 JST

Venue:

Event held online. A Zoom link will be sent to the participants beforehand.

Entry Fee:

Free of charge

Registration:

*Registration closed*

(Deadline: April 4)

*Spots are limited; SCCIJ members will be prioritized.*
*Kindly be noted that the webinar will be recorded.*

Inquiries:

By e-mail to info@sccij.jp

Biography of the Speaker:

Prof. Dr. Kenji Shibuya is currently Director of the University Institute for Population Health at King’s College London. His expertise ranges across important topics in global and population health including health metrics and evaluation; global burden of disease; health system performance; product and system innovations; public-private partnerships; and R&D strategies. Dr. Shibuya has been an advisor to both central and local governments, and was recently appointed as Special Advisor to the Director-General of the World Health Organization and a member of the Scientific Advisory Committee of Coalition for Epidemic Preparedness Innovations, a new pandemic vaccine fund investing in COVID-19 vaccines. He spearheaded the future strategic directions of the Japanese global health policy agenda at the Hokkaido Toyako G8 Summit in 2008 on health system strengthening and Ise-Shima G7 Summit in 2016 on global health security. He obtained his MD at the University of Tokyo and earned a doctorate of public health in international health economics at Harvard University.

Webinar: “Response to the COVID-19 Pandemic: Lessons from Japan and Abroad”

Sign up to our weekly newsletter to keep up-to-date with our latest news

LATEST NEWS